| Quantity | 1Set | 100µg, 5mg, 1mg, 10mg | 5KU, 1KU | 250mg, 5mg, 50mg, 10mg, 25mg | 10mg, 5mg, 50mg, 1mg, 25mg |
| Description | IPO7 Human Pre-designed siRNA Set A contains three designed siRNAs for IPO7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components IPO7 siRNA-1: 5 nmol (HPLC) IPO7 siRNA-2: 5 nmol (HPLC) IPO7 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 IPO7 Human Pre-designed siRNA Set A contains three designed siRNAs for IPO7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components IPO7 siRNA-1: 5 nmol (HPLC) IPO7 siRNA-2: 5 nmol (HPLC) IPO7 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Dezamizumab (anti-Serum Amyloid P) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab (anti-Serum Amyloid P) triggers immunotherapeutic clearance of amyloid. Dezamizumab (anti-Serum Amyloid P) can be used Dezamizumab (anti-Serum Amyloid P) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab (anti-Serum Amyloid P) triggers immunotherapeutic clearance of amyloid. Dezamizumab (anti-Serum Amyloid P) can be used in research of Amyloid light-chain (AL) amyloidosis... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Inquire | Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis... Read More |